Cantor Fitzgerald Reiterates Overweight on HCA Healthcare, Maintains $392 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on HCA Healthcare and maintained a price target of $392.
October 01, 2024 | 3:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on HCA Healthcare, maintaining a price target of $392. This suggests confidence in HCA's stock performance.
The reiteration of an Overweight rating and a maintained price target of $392 by a reputable analyst suggests a positive outlook for HCA Healthcare's stock. This could lead to increased investor confidence and potentially a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100